LX-7101

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameLX-7101
Drug Alias NameLX-7101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLIM domain kinase 2 inhibitors
TargetsLIM domain kinase 2
Therapy Area/IndicationsGlaucoma, Open-AngleOcular Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesLexicon Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLexicon Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsGlaucoma, Open-AngleOcular Hypertension

Other Information

ATC CodeN/A
Related LinksN/A